JP2016121177A5 - - Google Patents

Download PDF

Info

Publication number
JP2016121177A5
JP2016121177A5 JP2016041508A JP2016041508A JP2016121177A5 JP 2016121177 A5 JP2016121177 A5 JP 2016121177A5 JP 2016041508 A JP2016041508 A JP 2016041508A JP 2016041508 A JP2016041508 A JP 2016041508A JP 2016121177 A5 JP2016121177 A5 JP 2016121177A5
Authority
JP
Japan
Prior art keywords
compound
formula
mixture
alkyl
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016041508A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016121177A (ja
JP6087005B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2016121177A publication Critical patent/JP2016121177A/ja
Publication of JP2016121177A5 publication Critical patent/JP2016121177A5/ja
Application granted granted Critical
Publication of JP6087005B2 publication Critical patent/JP6087005B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016041508A 2011-01-21 2016-03-03 縮合アミノジヒドロチアジン誘導体の合成に有用な方法および化合物 Expired - Fee Related JP6087005B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161434849P 2011-01-21 2011-01-21
US61/434,849 2011-01-21

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2013550622A Division JP5993875B2 (ja) 2011-01-21 2012-01-20 縮合アミノジヒドロチアジン誘導体の合成に有用な方法および化合物

Publications (3)

Publication Number Publication Date
JP2016121177A JP2016121177A (ja) 2016-07-07
JP2016121177A5 true JP2016121177A5 (https=) 2016-09-01
JP6087005B2 JP6087005B2 (ja) 2017-03-01

Family

ID=45563570

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013550622A Expired - Fee Related JP5993875B2 (ja) 2011-01-21 2012-01-20 縮合アミノジヒドロチアジン誘導体の合成に有用な方法および化合物
JP2016041508A Expired - Fee Related JP6087005B2 (ja) 2011-01-21 2016-03-03 縮合アミノジヒドロチアジン誘導体の合成に有用な方法および化合物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2013550622A Expired - Fee Related JP5993875B2 (ja) 2011-01-21 2012-01-20 縮合アミノジヒドロチアジン誘導体の合成に有用な方法および化合物

Country Status (12)

Country Link
US (3) US8426584B2 (https=)
EP (1) EP2665716B1 (https=)
JP (2) JP5993875B2 (https=)
CN (2) CN106632401B (https=)
BR (1) BR112013016241A2 (https=)
CA (1) CA2814014A1 (https=)
ES (1) ES2624288T3 (https=)
IL (1) IL226405A0 (https=)
MX (1) MX2013005115A (https=)
RU (1) RU2013138226A (https=)
SG (2) SG10201601516QA (https=)
WO (1) WO2012100179A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2476431C2 (ru) 2008-01-18 2013-02-27 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Конденсированное производное аминодигидротиазина
GB0912777D0 (en) 2009-07-22 2009-08-26 Eisai London Res Lab Ltd Fused aminodihydropyrimidone derivatives
GB0912778D0 (en) 2009-07-22 2009-08-26 Eisai London Res Lab Ltd Fused aminodihydro-oxazine derivatives
GB201100181D0 (en) 2011-01-06 2011-02-23 Eisai Ltd Fused aminodihydrothiazine derivatives
GB201101140D0 (en) * 2011-01-21 2011-03-09 Eisai Ltd Fused aminodihydrothiazine derivatives
GB201101139D0 (en) * 2011-01-21 2011-03-09 Eisai Ltd Fused aminodihydrothiazine derivatives
UY34278A (es) 2011-08-25 2013-04-05 Novartis Ag Derivados novedosos de oxazina y su uso en el tratamiento de enfermedades
GB201212816D0 (en) * 2012-07-19 2012-09-05 Eisai Ltd Novel compounds
JO3318B1 (ar) 2013-06-18 2019-03-13 Lilly Co Eli مثبطات bace
SG11201702632QA (en) * 2014-10-10 2017-05-30 Eisai R&D Man Co Ltd Pharmaceutical composition of fused aminodihydrothiazine derivative
CN117244056A (zh) 2016-10-27 2023-12-19 卫材研究发展管理有限公司 用于治疗阿尔茨海默病的含有抗Aβ初原纤维抗体和β-分泌酶BACE1抑制剂的组合物
MX2021000778A (es) 2018-07-24 2021-03-31 Eisai R&D Man Co Ltd Metodos de tratamiento y prevencion de la enfermedad de alzheimer.

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3227713A (en) 1966-01-04 Azine derivatives
US3235551A (en) 1966-02-15 Novel derivatives of
JPH0967355A (ja) 1995-08-31 1997-03-11 Tokyo Tanabe Co Ltd チアジン誘導体、チアゾール誘導体及びそれらの製造方法
CN1251671C (zh) 2000-05-19 2006-04-19 武田药品工业株式会社 β分泌酶抑制剂
US6562783B2 (en) 2001-05-30 2003-05-13 Neurologic, Inc. Phosphinylmethyl and phosphorylmethyl succinic and glutauric acid analogs as β-secretase inhibitors
WO2004014843A1 (ja) 2002-08-09 2004-02-19 Takeda Chemical Industries, Ltd. 置換アミノ化合物およびその用途
WO2004037212A2 (en) 2002-10-24 2004-05-06 Sepracor, Inc. Compositions comprising zopiclone derivatives and methods of making and using the same
JP2004149429A (ja) 2002-10-29 2004-05-27 Takeda Chem Ind Ltd インドール化合物およびその用途
CA2505098A1 (en) 2002-11-12 2004-05-27 Merck & Co., Inc. Phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease
PT1699455E (pt) 2003-12-15 2013-08-27 Merck Sharp & Dohme Inibidores de protease de aspartilo heterocíclicos
JP2007530696A (ja) 2004-03-30 2007-11-01 メルク エンド カムパニー インコーポレーテッド アスパラギン酸プロテアーゼ阻害剤として有用な2−アミノチアゾール化合物
PE20060664A1 (es) 2004-09-15 2006-08-04 Novartis Ag Amidas biciclicas como inhibidores de cinasa
EP1802587A4 (en) 2004-10-15 2010-02-17 Astrazeneca Ab SUBSTITUTED AMINO BINDINGS AND THEIR APPLICATIONS
WO2006041405A1 (en) 2004-10-15 2006-04-20 Astrazeneca Ab Substituted amino-pyrimidones and uses thereof
CA2594946A1 (en) 2005-01-19 2006-07-27 Merck & Co., Inc Tertiary carbinamines having substituted heterocycles, which are active as inhibitors of beta-secretase, for the treatment of alzheimer's disease
MX2007016180A (es) 2005-06-14 2008-03-07 Schering Corp Inhibidores de aspartil proteasas.
US8211904B2 (en) 2005-07-18 2012-07-03 Merck, Sharp & Dohme Corp. Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
RU2416603C9 (ru) 2005-10-25 2012-06-20 Сионоги Энд Ко., Лтд. Производные аминодигидротиазина
US20090099217A1 (en) 2006-04-05 2009-04-16 Astex Therapeutics Ltd. 2-Aminopyrimidin-4-Ones And Their Use For Treating Or Preventing Alpha Beta-Related Pathologies
JP5117382B2 (ja) 2006-05-31 2013-01-16 第一三共株式会社 7員環化合物の製造方法
AU2007332754A1 (en) 2006-12-12 2008-06-19 Schering Corporation Aspartyl protease inhibitors
EP2147914B1 (en) 2007-04-24 2014-06-04 Shionogi&Co., Ltd. Aminodihydrothiazine derivatives substituted with cyclic groups
EP2151435A4 (en) 2007-04-24 2011-09-14 Shionogi & Co PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALZHEIMER'S DISEASE
ES2419239T3 (es) 2007-05-29 2013-08-20 Santen Pharmaceutical Co., Ltd Nuevo derivado de 1,2,3,4-tetrahidroquinoxalina que tiene como sustituyente un grupo fenilo con una estructura de éster de ácido sulfónico o una estructura de amida de ácido sulfónico introducida en el mismo y que tienen una actividad de unión al receptor de glucocorticoides
PE20091236A1 (es) 2007-11-22 2009-09-16 Astrazeneca Ab Derivados de pirimidina como immunomoduladores de tlr7
RU2476431C2 (ru) 2008-01-18 2013-02-27 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Конденсированное производное аминодигидротиазина
TWI431004B (zh) 2008-05-02 2014-03-21 Lilly Co Eli Bace抑制劑
WO2010013302A1 (ja) 2008-07-28 2010-02-04 エーザイ・アール・アンド・ディー・マネジメント株式会社 スピロアミノジヒドロチアジン誘導体
EP2318416B1 (en) 2008-07-28 2013-09-04 Eisai R&D Management Co., Ltd. Spiroaminodihydrothiazine derivatives
KR20110076965A (ko) 2008-09-30 2011-07-06 에자이 알앤드디 매니지먼트 가부시키가이샤 신규한 축합 아미노 디하이드로티아진 유도체
AR077277A1 (es) 2009-07-09 2011-08-17 Lilly Co Eli Compuestos de biciclo (1,3)tiazin-2-amina formulacion farmaceutica que lo comprende y su uso para la manufactura de un medicamento util para el tratamiento de la enfermedad de alzheimer
GB0912778D0 (en) * 2009-07-22 2009-08-26 Eisai London Res Lab Ltd Fused aminodihydro-oxazine derivatives
GB0912777D0 (en) 2009-07-22 2009-08-26 Eisai London Res Lab Ltd Fused aminodihydropyrimidone derivatives
JP2013530238A (ja) 2010-07-01 2013-07-25 アムジエン・インコーポレーテツド Pi3k活性の阻害剤としての複素環化合物及びその使用
GB201101140D0 (en) 2011-01-21 2011-03-09 Eisai Ltd Fused aminodihydrothiazine derivatives

Similar Documents

Publication Publication Date Title
JP2016121177A5 (https=)
JP2014503001A5 (https=)
JP2018193405A5 (https=)
JP6050358B2 (ja) ベンゾオキサジノンをアミンと反応させることによるテトラゾール置換アントラニル酸ジアミド誘導体の製造方法
JP2005530694A5 (https=)
RU2013138226A (ru) Способы и соединения, пригодные для получения конденсированных аминодигидротиазиновых производных
JP2006137778A5 (https=)
JP2013533267A5 (https=)
JP2017505801A5 (https=)
JP2019504840A5 (https=)
JP2013508368A5 (https=)
JPWO2014024682A1 (ja) ビス(ハロスルホニル)アミンの製造方法
CN106279104A (zh) 一种制备琥珀酸曲格列汀的工艺改进方法
EP3608324B1 (en) Method for preparing 2-arylmalonamide and applications of this method
JP6239003B2 (ja) 4−アミノ−5−フルオロ−3−クロロ−6−(置換)ピコリネートの調製方法
TWI621609B (zh) 製備4-鹵烷基-3-巰基-取代之2-羥基苯甲酸衍生物
JP2007517012A5 (https=)
JP2008247753A5 (https=)
JP2014009330A5 (https=)
CN108689874B (zh) 一种制备2-芳基丙二酰胺的方法及其应用
TW201326116A (zh) 2,6-二乙基-4-甲基苯醋酸之製造方法
WO2017056501A1 (ja) 酸ハライド溶液の製造方法、混合溶液、及びモノエステル化合物の製造方法
JP2015524846A5 (https=)
CN105037331B (zh) 瑞舒伐他汀中间体的制备方法
WO2003014067A1 (fr) Methode de production d'un compose beta-oxonitrile ou d'un sel de metal alcalin dudit compose